Rapamune

Product
Active substances: sirolimus. Therapeutic area: Graft Rejection;Kidney Transplantation
Reason
Quality defect
Classification
Class I
Category
drug recall
Country
European Union
Agency
EMA-DHPC
Recall date
2025-09-19
Status
Ongoing
Distribution
European Union

Official recall notice from EMA-DHPC

Recall details on Nibble Recalls: https://trynibble.app/recalls/ee753530-7e0d-4323-8259-ff679984cee5